HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART
- PMID: 27460436
- PMCID: PMC5049918
- DOI: 10.1016/j.ebiom.2016.07.024
HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART
Abstract
HIV DNA is a marker of HIV persistence that predicts HIV progression and remission, but its kinetics in early acute HIV infection (AHI) is poorly understood. We longitudinally measured the frequency of peripheral blood mononuclear cells harboring total and integrated HIV DNA in 19 untreated and 71 treated AHI participants, for whom 50 were in the earliest Fiebig I/II (HIV IgM-) stage, that is ≤2weeks from infection. Without antiretroviral therapy (ART), HIV DNA peaked at 2weeks after enrollment, reaching a set-point 2weeks later with little change thereafter. There was a marked divergence of HIV DNA values between the untreated and treated groups that occurred within the first 2weeks of ART and increased with time. ART reduced total HIV DNA levels by 20-fold after 2weeks and 316-fold after 3years. Therefore, very early ART offers the opportunity to significantly reduce the frequency of cells harboring HIV DNA.
Keywords: Acute HIV infection; Art; HIV DNA; Persistence; Reservoir.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.
Figures



References
-
- Ananworanich J., Schuetz A., Vandergeeten C., Sereti I., De Souza M., Rerknimitr R., Dewar R., Marovich M., van Griensven F., Sekaly R., Pinyakorn S., Phanuphak N., Trichavaroj R., Rutvisuttinunt W., Chomchey N., Paris R., Peel S., Valcour V., Maldarelli F., Chomont N., Michael N., Phanuphak P., Kim J.H., Group, R. S. S. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One. 2012;7 - PMC - PubMed
-
- Ananworanich J., Fletcher J.L., Pinyakorn S., van Griensven F., Vandergeeten C., Schuetz A., Pankam T., Trichavaroj R., Akapirat S., Chomchey N., Phanuphak P., Chomont N., Michael N.L., Kim J.H., de Souza M., Group, R. S. S. A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology. 2013;10:56. - PMC - PubMed
-
- Ananworanich J., Chomont N., Fletcher J.L., Pinyakorn S., Schuetz A., Sereti I., Rerknimitr R., Dewar R., Kroon E., Vandergeeten C., Trichavaroj R., Chomchey N., Chalermchai T., Michael N.L., KIM J.H., Phanuphak P., Phanuphak N. Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification. J. Virus Erad. 2015;1:116–122. - PMC - PubMed
-
- Buzon M.J., Martin-Gayo E., Pereyra F., Ouyang Z., Sun H., Li J.Z., Piovoso M., Shaw A., Dalmau J., Zangger N., Martinez-Picado J., Zurakowski R., Yu X.G., Telenti A., Walker B.D., Rosenberg E.S., Lichterfeld M. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J. Virol. 2014;88:10056–10065. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical